Cite
Mass balance and metabolite profiling of 14 C-guadecitabine in patients with advanced cancer.
MLA
Roosendaal, Jeroen, et al. “Mass Balance and Metabolite Profiling of 14 C-Guadecitabine in Patients with Advanced Cancer.” Investigational New Drugs, vol. 38, no. 4, Aug. 2020, pp. 1085–95. EBSCOhost, https://doi.org/10.1007/s10637-019-00854-9.
APA
Roosendaal, J., Rosing, H., Lucas, L., Gebretensae, A., Huitema, A. D. R., van Dongen, M. G., Beijnen, J. H., & Oganesian, A. (2020). Mass balance and metabolite profiling of 14 C-guadecitabine in patients with advanced cancer. Investigational New Drugs, 38(4), 1085–1095. https://doi.org/10.1007/s10637-019-00854-9
Chicago
Roosendaal, Jeroen, Hilde Rosing, Luc Lucas, Abadi Gebretensae, Alwin D R Huitema, Marloes G van Dongen, Jos H Beijnen, and Aram Oganesian. 2020. “Mass Balance and Metabolite Profiling of 14 C-Guadecitabine in Patients with Advanced Cancer.” Investigational New Drugs 38 (4): 1085–95. doi:10.1007/s10637-019-00854-9.